Published on 23 Nov 2022 on Zacks via Yahoo Finance
Shares of Palisade Bio PALI were up 81.08% during market hours after the company announced that its lead asset, LB1148, a protease inhibitor has been granted Fast Track designation by the FDA for accelerated return of bowel function following gastrointestinal (GI) surgery.However, the stock has plunged 100% in the year-to-date period compared with the industry’s fall of 17.8%.
Zacks Investment Research
Image Source: Zacks Investment Research